Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estriol plus Copaxone in RRMS
NCT00451204Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Mar 2007
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of estriol in relapsing-remitting multiple sclerosis (RRMS), sponsored by University of California, Los Angeles. Started Mar 2007; status: completed.
02
Drugs
estriol
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00451204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451204.